bolsia
Portfolios
Blog
Forex
Clubs
Forum
Groups
Login
Registrarse
IBEX
8,702
0.97%
EUROSTOXX50
3,395
1.33%
FTSE
7,204
1.11%
DAX
11,803
1.30%
Stocks
Portfolios
Portfolios
Stocks
Recent Trades
Bolsia Coins
Referrals
FAQs
US Stocks
Buy Stocks
Chart
Maximum Portfolio Game:
25%
Company
Quote
Time
Biogen Idec Inc (BIIB)
$320.48
(-1.65%)
21:00
(20/03/2019)
Portfolios Holding
BIIB
Sbronson 57.6%
Xarly91 52.1%
Jcasielles 50.9%
News
Southern Copper Moves Up In Market Cap Rank, Passing Biogen Idec
BIOGEN IDEC INC. : Biogen Idec to Report Fourth Quarter & Year End 2012 ...
Biogen Idec and Elan Submit Applications for First-Line Use of TYSABRI in anti ...
Biogen Idec seeks regulatory OK's for wider use of a multiple sclerosis drug
Biogen Idec Inc., Elan Corporation, Chevron Corporation, CNOOC Ltd., and ...
Biogen Idec Inc's Lou Gehrig's Disease Drug Fails In Key Trial-Reuters
Cramer's Mad Money - The Unsinkable Biogen IDEC (1/8/13)
Biogen Needs Strong BG-12 Launch to Maintain Momentum
BIOGEN IDEC INC. : Biogen Idec Submits Application to FDA for First Long ...
Biogen Idec seeks approval for hemophilia B drug
Bulls and Bears: Hewlett Packard (NYSE:HPQ), Biogen Idec Inc. (NASDAQ:BIIB)
Biogen Idec to Present at the 31st Annual JP Morgan Healthcare Conference
Biogen Idec (BIIB) To Discontinue Development Of Dexpramipexole In ALS ...
Analyst Downgrades: Biogen Idec, AT&T, and UnitedHealth Group
Lou Gehrig's Disease Drug Failure Crushes Biogen Idec
BIOGEN IDEC INC. : Biogen Stops Development of Lou Gehrig's Disease Drug
BIOGEN IDEC INC. : Biogen Discontinues Development of Dexpramipexole as ...
Biogen Idec gives up on experimental drug to treat Lou Gehrig's disease
Celgene Corp. Now #88 Largest Company, Surpassing Biogen Idec
Share via e-mail